These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12505248)

  • 1. Women's angiographic vitamin and estrogen trial: design and methods.
    Hsia J; Alderman EL; Verter JI; Rogers WJ; Thompson P; Howard BV; Cobb FR; Ouyang P; Tardif JC; Higginson L; Bittner V; Barofsky I; Steffes M; Gordon DJ; Proschan M; Younes N; Waters D
    Control Clin Trials; 2002 Dec; 23(6):708-27. PubMed ID: 12505248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.
    Waters DD; Alderman EL; Hsia J; Howard BV; Cobb FR; Rogers WJ; Ouyang P; Thompson P; Tardif JC; Higginson L; Bittner V; Steffes M; Gordon DJ; Proschan M; Younes N; Verter JI
    JAMA; 2002 Nov; 288(19):2432-40. PubMed ID: 12435256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort.
    Herrington DM; Reboussin DM; Klein KP; Sharp PC; Shumaker SA; Snyder TE; Geisinger KR
    Control Clin Trials; 2000 Jun; 21(3):257-85. PubMed ID: 10822123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trial.
    Kelemen M; Vaidya D; Waters DD; Howard BV; Cobb F; Younes N; Tripputti M; Ouyang P
    Atherosclerosis; 2005 Mar; 179(1):193-200. PubMed ID: 15721027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study).
    Patel D; Ahmad S; Silverman A; Lindsay J
    Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline.
    Resnick SM; Coker LH; Maki PM; Rapp SR; Espeland MA; Shumaker SA
    Clin Trials; 2004; 1(5):440-50. PubMed ID: 16279282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen therapy and coronary-artery calcification.
    Manson JE; Allison MA; Rossouw JE; Carr JJ; Langer RD; Hsia J; Kuller LH; Cochrane BB; Hunt JR; Ludlam SE; Pettinger MB; Gass M; Margolis KL; Nathan L; Ockene JK; Prentice RL; Robbins J; Stefanick ML;
    N Engl J Med; 2007 Jun; 356(25):2591-602. PubMed ID: 17582069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
    Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S;
    JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women.
    Levy AP; Friedenberg P; Lotan R; Ouyang P; Tripputi M; Higginson L; Cobb FR; Tardif JC; Bittner V; Howard BV
    Diabetes Care; 2004 Apr; 27(4):925-30. PubMed ID: 15047650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC; Felson DT; Williams EN; Grady D
    Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.
    Kanaya AM; Herrington D; Vittinghoff E; Lin F; Grady D; Bittner V; Cauley JA; Barrett-Connor E;
    Ann Intern Med; 2003 Jan; 138(1):1-9. PubMed ID: 12513038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
    Herrington DM; Reboussin DM; Brosnihan KB; Sharp PC; Shumaker SA; Snyder TE; Furberg CD; Kowalchuk GJ; Stuckey TD; Rogers WJ; Givens DH; Waters D
    N Engl J Med; 2000 Aug; 343(8):522-9. PubMed ID: 10954759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.
    Grady D; Applegate W; Bush T; Furberg C; Riggs B; Hulley SB
    Control Clin Trials; 1998 Aug; 19(4):314-35. PubMed ID: 9683309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary Artery Calcification (CAC) and Post-Trial Cardiovascular Events and Mortality Within the Women's Health Initiative (WHI) Estrogen-Alone Trial.
    Poornima IG; Mackey RH; Allison MA; Manson JE; Carr JJ; LaMonte MJ; Chang Y; Kuller LH;
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and coronary angiographic disease progression: the Women's Angiographic Vitamin & Estrogen trial.
    Hsia J; Bittner V; Tripputi M; Howard BV
    Am Heart J; 2003 Sep; 146(3):439-45. PubMed ID: 12947360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
    Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
    Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.
    Control Clin Trials; 1998 Feb; 19(1):61-109. PubMed ID: 9492970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.